Premier Alternatives

VerAvanti

Bothell, WA · Founded 2013 · Privately Held (backing)

Developer of a scanning fiber endoscope device designed to identify the causes of strokes and cardiac events. VerAvanti is based in Bothell, WA and was founded in 2013. It was valued at $161 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $43.4 million across 2 recorded rounds; the latest was a $28.3 million early-stage round in Feb 2025.

PMV mark · valuation
$161.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$43.4M
Last round
Early Stage VC
Feb 2025

VerAvanti key facts

as of Oct 2026
  • Developer of a scanning fiber endoscope device designed to identify the causes of strokes and cardiac events.
  • VerAvanti is valued at approximately $161.0M as of Oct 2026, set at its later-stage round, Oct 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $43.4M across 2 recorded rounds; the latest was Early Stage VC ($28.3M) in Feb 2025.
  • Notable investors include Lung, National Cancer Institute, National Heart, UW CoMotion, University of Washington — 6 tracked in total.
  • VerAvanti has filed 2 Form Ds with the SEC since 2017, most recently Mar 2025 ($28.3M sold to 17 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$161.0M

Valued at $161.0M at its later-stage round, Oct 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of VerAvanti with a free account
  • ·Watch VerAvanti: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

VerAvanti funding rounds

2 rounds
Feb 2025Early Stage VC$28.3MSEC filing▮
May 2017Seed Round$540KSEC filing▮
Full funding history →

VerAvanti valuation

VerAvanti was valued at $161 million at its later-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has VerAvanti raised?

VerAvanti has raised $43.4 million in total; 2 of its rounds are on record. The largest on record was a $540,000 seed round in May 2017; the most recent was a $28.3 million early-stage round in Feb 2025.

VerAvanti has filed 2 Form Ds with the SEC since 2017, most recently in Mar 2025 ($28.3 million sold to 17 investors).

VerAvanti investors

6 investors are on record for VerAvanti, including Lung, National Cancer Institute, National Heart and UW CoMotion. The early-stage round in Feb 2025 drew 17 investors.

About VerAvanti

Developer of a scanning fiber endoscope device designed to identify the causes of strokes and cardiac events. The company's device consists of an imaging station and a tiny catheter that is designed to take high-definition images, enabling doctors and surgeons to have a peek into hidden intravascular anatomy and visually identify potential risks for stroke and cardiovascular risks.

Sector
Healthcare
HQ
Bothell, WA, United States
Founded
2013
Employees
18
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.